Published online Mar 26, 2020. doi: 10.12998/wjcc.v8.i6.1026
Peer-review started: December 20, 2019
First decision: January 7, 2020
Revised: January 15, 2020
Accepted: March 5, 2020
Article in press: March 5, 2020
Published online: March 26, 2020
Processing time: 96 Days and 23.2 Hours
Core tip: Distal esophageal spasm (DES) is an esophageal motor disorder that is diagnosed using high-resolution manometry and is classified as a major motility disorder in the Chicago classification of esophageal motility disorder. While the criteria for diagnosis have been revised overtime to achieve a homogenous clinical entity, presentation of DES continues to be heterogenous. This has led to the usage of multiple pharmacological treatment options such as nitrates, phosphodiesterase inhibitors, calcium channel blockers, and tricyclic antidepressants, often resulting in poor symptom management. DES pathophysiology falls within the spectrum of spastic motility disorders, and it may represent a stage in the process of evolution to achalasia, more likely type 3. Patients who have continued symptoms despite medical management might benefit from endoscopic procedures such as botulinum injection and peroral endoscopic myotomy.
